follow us in feedly
MicroCapNewsDaily
  • Mining
  • Cannabis
  • Energy
  • Tech
  • Health
  • Biotech
  • Price Charts

Join Our Community

Facebook

Twitter

RSS

      HomeBiotech

      Biotech

      No Picture
      Biotech

      INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

      Jan 22 MicroCapNewsDaily
      INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm PR Newswire LOS more...
      No Picture
      Biotech

      CELSION CORPORATION ANNOUNCES $35 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

      Jan 22 MicroCapNewsDaily
      LAWRENCEVILLE, NJ, Jan. 22, 2021 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institutional investors for the purchase and sale of 25,925,925 shares of more...
      No Picture
      Biotech

      aTyr Pharma to Present Poster Highlighting Research Approach for Identifying Receptor Targets for Extracellular tRNA Synthetases

      Jan 22 MicroCapNewsDaily
      Poster to be presented at the 2021 Society for Laboratory Automation and Screening Digital International Conference and Exhibition. Research approach led to the identification of target receptors for two tRNA synthetases and further validates company’s more...
      No Picture
      Biotech

      Equillium Announces Acceptance of Late-Breaking Abstract for Oral Presentation of Interim Data from EQUATE Study in acute GVHD at the 2021 TCT Meetings Digital Experience

      Jan 22 MicroCapNewsDaily
      LA JOLLA, Calif., Jan. 22, 2021 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced that interim data from the Phase 1b/2 more...
      No Picture
      Biotech

      Immutep Quarterly Activities Report

      Jan 21 MicroCapNewsDaily
      Highlights Encouraging efti data reported from phase IIb AIPAC and phase II TACTI-002 clinical trials TACTI-002 study expanded in lung cancer New phase II trial in head and neck cancer announced EOC Pharma starts new more...
      No Picture
      Biotech

      Ulcerative Colitis Phase II Study of GSK2831781 Discontinued

      Jan 21 MicroCapNewsDaily
      Immutep’s Collaboration and Exclusive License with GSK Remains in Place Sydney, AUSTRALIA, Jan. 22, 2021 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments more...
      No Picture
      Biotech

      ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action – FBIO

      Jan 21 MicroCapNewsDaily
      NEW YORK, Jan. 21, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019 and October 9, more...
      No Picture
      Biotech

      SHAREHOLDER ALERT: WeissLaw LLP Reminds CPAH, CATM, ANCN and GNBF Shareholders About Its Ongoing Investigations

      Jan 21 MicroCapNewsDaily
      SHAREHOLDER ALERT: WeissLaw LLP Reminds CPAH, CATM, ANCN and GNBF Shareholders About Its Ongoing Investigations PR Newswire NEW YORK , Jan. 21, 2021 /PRNewswire/ — If you own shares in any of the companies listed more...
      No Picture
      Biotech

      SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of INFO, PS, CATM, and ANCN Mergers

      Jan 21 MicroCapNewsDaily
      WILMINGTON, Del., Jan. 21, 2021 (GLOBE NEWSWIRE) — Rigrodsky Law, P.A. announces that it is investigating: IHS Markit Ltd. (NYSE: INFO ) regarding possible breaches of fiduciary duties and other violations of law related to more...
      No Picture
      Biotech

      DEADLINE ALERT for FBIO, SPLK, and BSX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

      Jan 21 MicroCapNewsDaily
      LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have more...

      Posts navigation

      1 2 … 210 »

      Get Hot Stock Alerts Delivered to Your Inbox

      GET ALERTS
      Privacy

      Biotech

      • INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

        Jan 22 MicroCapNewsDaily
        January 22, 2021
        INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact more...
      • CELSION CORPORATION ANNOUNCES $35 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

        Jan 22 MicroCapNewsDaily
        January 22, 2021
        LAWRENCEVILLE, NJ, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institut more...
      • aTyr Pharma to Present Poster Highlighting Research Approach for Identifying Receptor Targets for Extracellular tRNA Synthetases

        Jan 22 MicroCapNewsDaily
        January 22, 2021
        Poster to be presented at the 2021 Society for Laboratory Automation and Screening Digital International Conference and Exhibition. Research approach led to the more...
      • Equillium Announces Acceptance of Late-Breaking Abstract for Oral Presentation of Interim Data from EQUATE Study in acute GVHD at the 2021 TCT Meetings Digital Experience

        Jan 22 MicroCapNewsDaily
        January 22, 2021
        LA JOLLA, Calif., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory more...
      • Immutep Quarterly Activities Report

        Jan 21 MicroCapNewsDaily
        January 21, 2021
        Highlights Encouraging efti data reported from phase IIb AIPAC and phase II TACTI-002 clinical trials TACTI-002 study expanded in lung cancer New more...
      • Ulcerative Colitis Phase II Study of GSK2831781 Discontinued

        Jan 21 MicroCapNewsDaily
        January 21, 2021
        Immutep’s Collaboration and Exclusive License with GSK Remains in Place Sydney, AUSTRALIA, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) more...
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2021 | 244 Fifth Avenue, Suite N-249 New York, N.Y. 10001 USA | 1-866-773-3540

      Copyright © 2021 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      244 Fifth Avenue, Suite N-249 New York, N.Y. 10001 USA | 1-866-773-3540